Funds and ETFs Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.
Equities
874
CNE100000387
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.9 HKD | -1.72% | -0.22% | +5.29% |
04-26 | Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-18 | Baiyunshan Pharmaceutical's 2023 Profit Rises 2% | MT |
ETFs positioned on Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.09% | 4 M€ | -27.92% | ||
0.00% | 32 M€ | +7.39% | - | |
0.00% | 34 M€ | +4.49% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.29% | 6.87B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.51% | 238B | |
+6.85% | 204B | |
-6.63% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- 874 Stock
- Funds and ETFs Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.